BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2022 7:03:59 AM | Browse: 303 | Download: 593
 |
Received |
|
2021-10-13 11:24 |
|
Peer-Review Started |
|
2021-10-13 11:26 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-11 07:10 |
|
Revised |
|
2022-01-24 08:56 |
|
Second Decision |
|
2022-06-24 03:15 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-24 18:28 |
|
Articles in Press |
|
2022-06-24 18:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-05-31 11:33 |
|
Typeset the Manuscript |
|
2022-06-29 06:22 |
|
Publish the Manuscript Online |
|
2022-07-22 07:03 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Latamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ruo-Ying Zhang, Jun-Jie Zhang, Jin-Meng Li, Ying-Ying Xu, Yue-Huan Xu and Xin-Jun Cai |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hospital Pharmacy of Zhejiang Pharmaceutical Society |
2019ZYY27 |
| Zhejiang Medical and Health Science and Technology Plan |
2020KY741 |
| Zhejiang Medical and Health Science and Technology Plan |
2021KY910 |
|
| Corresponding Author |
Xin-Jun Cai, Doctor, Chief Pharmacist, Department of Pharmacy, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, 208 East Huancheng Road, Hangzhou, China, Hangzhou 310000, Zhejiang Province, China. zjtcmcxj@zcmu.edu.cn |
| Key Words |
Thrombocytopenia; Latamoxef; Adverse drug reactions; Young onset; Csae report |
| Core Tip |
We described a case of severe thrombocytopenia likely induced by latamoxef, an infrequent adverse drug reaction in a young patient with tuberculosis and Crohn's. We followed the changes in platelet counts and the appearance of purpura during latamoxef treatment and after drug withdrawal and excluded other possible causes of thrombocytopenia. Our findings suggested that the patient's thrombocytopenia was caused by latamoxef. This is the first reported case of severe thrombocytopenia induced by latamoxef in a young Chinese patient to the best of our knowledge. |
| Publish Date |
2022-07-22 07:03 |
| Citation |
Zhang RY, Zhang JJ, Li JM, Xu YY, Xu YH, Cai XJ. Latamoxef-induced severe thrombocytopenia during the treatment of pulmonary infection: A case report. World J Clin Cases 2022; 10(22): 7906-7912 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i22/7906.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i22.7906 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
